Wegovy — Cigna
Weight Loss in a Pediatric Patient with Obesity
Initial criteria
- Patient age ≥ 12 years and < 18 years
- Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months
- At baseline, patient had a BMI ≥ 95th percentile for age and sex
- The medication will be used concomitantly with behavioral modification and a reduced-calorie diet
Reauthorization criteria
- Patient age ≥ 12 years and < 18 years
- At baseline, patient had a BMI ≥ 95th percentile for age and sex
- Patient has had a reduction in BMI of ≥ 1% from baseline
- The medication will be used concomitantly with behavioral modification and a reduced-calorie diet
Approval duration
initial 7 months, reauth 1 year